Genocea Biosciences Inc (GNCA) Jumps 7.87% on December 23

Equities Staff |

Genocea Biosciences Inc (GNCA) was among the biggest gainers on the Russell 2000 for Wednesday December 23 as the stock popped 7.87% to $6.44, representing a gain of $0.47 per share. Some 219,074 shares traded hands on 1,257 trades, compared with an average daily volume of 306,807 shares out of a total float of 28.12 million. The stock opened at $5.99 and traded with an intraday range of $6.48 to $5.89.

After today's gains, Genocea Biosciences Inc reached a market cap of $181.06 million. Genocea Biosciences Inc has had a trading range between $16.18 and $4.27 over the last year, and it had a 50-day SMA of $5.90 and a 200-day SMA of $10.15.

Genocea Biosciences Inc is a clinical stage biopharmaceutical company that discovers and develops novel vaccines to address infectious diseases for which no vaccine or vaccines with limited effectiveness exist today.

Genocea Biosciences Inc is based out of Cambridge, MA and has some 57 employees. Its CEO is William D. Clark.

For a complete fundamental analysis analysis of Genocea Biosciences Inc, check out’s Stock Valuation Analysis report for GNCA. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

GSV Capital Corp

GSV Capital Corp is an externally managed, non-diversified closed-end management investment company. The Company has elected to be treated as a business development company.

Private Markets


D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…


Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.